NO20042379L - Pharmaceutical preparation comprising factor VII polypeptides and PAI-1 polypeptides - Google Patents

Pharmaceutical preparation comprising factor VII polypeptides and PAI-1 polypeptides

Info

Publication number
NO20042379L
NO20042379L NO20042379A NO20042379A NO20042379L NO 20042379 L NO20042379 L NO 20042379L NO 20042379 A NO20042379 A NO 20042379A NO 20042379 A NO20042379 A NO 20042379A NO 20042379 L NO20042379 L NO 20042379L
Authority
NO
Norway
Prior art keywords
polypeptides
pai
pharmaceutical preparation
factor vii
vii polypeptides
Prior art date
Application number
NO20042379A
Other languages
Norwegian (no)
Inventor
Rasmus Rojkjaer
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Publication of NO20042379L publication Critical patent/NO20042379L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20042379A 2001-11-09 2004-06-08 Pharmaceutical preparation comprising factor VII polypeptides and PAI-1 polypeptides NO20042379L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101671 2001-11-09
PCT/DK2002/000735 WO2003039580A1 (en) 2001-11-09 2002-11-05 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides

Publications (1)

Publication Number Publication Date
NO20042379L true NO20042379L (en) 2004-06-08

Family

ID=8160829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042379A NO20042379L (en) 2001-11-09 2004-06-08 Pharmaceutical preparation comprising factor VII polypeptides and PAI-1 polypeptides

Country Status (15)

Country Link
EP (1) EP1446146A1 (en)
JP (1) JP2005510514A (en)
KR (1) KR20050043733A (en)
CN (1) CN1596122A (en)
AU (1) AU2002340778B2 (en)
BR (1) BR0213952A (en)
CA (1) CA2464614A1 (en)
CZ (1) CZ2004535A3 (en)
HU (1) HUP0401959A3 (en)
IL (1) IL161523A0 (en)
NO (1) NO20042379L (en)
PL (1) PL370118A1 (en)
RU (1) RU2304980C2 (en)
WO (1) WO2003039580A1 (en)
ZA (1) ZA200403270B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009045412A2 (en) * 2007-10-01 2009-04-09 American Diagnostica, Inc. Methods of treatment using modified plasminogen activator inhibitor type-1 molecules
WO2020103930A1 (en) * 2018-11-22 2020-05-28 上海科技大学 Thiazolo ring compound, preparation method therefor, intermediate thereof, and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2214833C2 (en) * 1994-10-24 2003-10-27 Ново Нордиск Хелс Кеар Аг Modified factor vii
AU7907398A (en) * 1997-06-23 1999-01-04 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
AT409335B (en) * 1998-11-10 2002-07-25 Immuno Ag PHARMACEUTICAL PREPARATION CONTAINING A RECEPTOR ANTAGONIST FOR THE TREATMENT OF BLOOD COagulation disorders
EP1282693B1 (en) * 2000-05-03 2010-10-20 Novo Nordisk Health Care AG Human coagulation factor vii variants

Also Published As

Publication number Publication date
WO2003039580A1 (en) 2003-05-15
RU2304980C2 (en) 2007-08-27
RU2004117535A (en) 2005-04-10
EP1446146A1 (en) 2004-08-18
HUP0401959A2 (en) 2004-12-28
JP2005510514A (en) 2005-04-21
PL370118A1 (en) 2005-05-16
HUP0401959A3 (en) 2009-03-30
CA2464614A1 (en) 2003-05-15
ZA200403270B (en) 2004-11-08
IL161523A0 (en) 2004-09-27
AU2002340778B2 (en) 2007-08-02
CN1596122A (en) 2005-03-16
BR0213952A (en) 2004-08-31
CZ2004535A3 (en) 2005-01-12
KR20050043733A (en) 2005-05-11

Similar Documents

Publication Publication Date Title
NO20044192L (en) 17alpha-alkyl-17beta-oxy-ostratrienes and pharmaceutical preparations
NO20033143D0 (en) Pharmaceutical preparation
DK1417175T3 (en) SUBSTITUTED DIHYDRO-3-HALO-1H-PYRAZOL-5-CARBOXYLATES AND PREPARATION AND USE THEREOF
PL367180A1 (en) Durable pharmaceutical composition
FI20011478A0 (en) Pharmaceutical composition
NO20033556D0 (en) Pharmaceutical preparations
HUP0500989A2 (en) Animicrobial polypeptides and their uses
HUP0500060A3 (en) Human coagulation factor vii polypeptides
DK200300344U1 (en) Amlodipine maleate and pharmaceutical composition containing amlodipine maleate
NO20025805L (en) Pharmaceutical preparation
GB0108470D0 (en) Pharmaceutical compositions and their use
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
NO20040235L (en) Pharmaceutical preparation comprising Factor VII polypeptides and Factor XI polypeptides
IL159872A0 (en) Gmg-2 polypeptides and their use
EP1462455A4 (en) Novel peptides and medicinal uses thereof
DE60217390D1 (en) BICALUTAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION
NO20042380L (en) Pharmaceutical preparation comprising factor VII polypeptides and factor V polypeptides
IL156711A0 (en) Peptide derivatives and pharmaceutical compositions containing the same
NO20042379L (en) Pharmaceutical preparation comprising factor VII polypeptides and PAI-1 polypeptides
DE10291905D2 (en) Pharmaceutical composition
NO20015534D0 (en) Pharmaceutical mixer
DE10107261B4 (en) Pharmaceutical composition
AU2002340777A1 (en) Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
AU2002340784A1 (en) Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides
DK200100256U3 (en) Amlodipine maleate and pharmaceutical preparations containing this